Showing results (1081-1090 of 1,170) with videos related to
Sort By:
Pageof 117
Proceedings of the National Academy of Sciences of the United States of America|July 22, 2022
Plant genetic effects on microbial hubs impact host fitness in repeated field trialsBenjamin Brachi, Daniele Filiault, Hannah Whitehurst, et al.Biorxiv : the Preprint Server for Biology|June 6, 2025
Life-history trade-offs explain local adaptation in Arabidopsis thalianaBenjamin Brachi, Danièle L Filiault, Rahul Pisupati, et al.Frontiers in Neurology|March 18, 2022
Relaxation-Compensated Chemical Exchange Saturation Transfer MRI in the Brain at 7T: Application in Relapsing-Remitting Multiple SclerosisKristin P O'Grady, Sanjana Satish, Quinn R Owen, et al.Proceedings of the National Academy of Sciences of the United States of America|July 13, 2012
Bedrock displacements in Greenland manifest ice mass variations, climate cycles and climate changeMichael Bevis, John Wahr, Shfaqat A Khan, et al.Molecular Cancer Therapeutics|June 23, 2017
Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic MelanomaJoo Ern Ang, Akos Pal, Yasmin J Asad, et al.Journal of Medicinal Chemistry|October 10, 2012
Optimization of imidazo[4,5-b]pyridine-based kinase inhibitors: identification of a dual FLT3/Aurora kinase inhibitor as an orally bioavailable preclinical development candidate for the treatment of acute myeloid leukemiaVassilios Bavetsias, Simon Crumpler, Chongbo Sun, et al.Blood Advances|April 14, 2020
Quizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736Andrew S Moore, Amir Faisal, Grace W Y Mak, et al.Oncogene|October 25, 2018
Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancerSteve Wagner, Georgios Vlachogiannis, Alexis De Haven Brandon, et al.Gastroenterology|July 2, 2013
Randomized controlled trial of danoprevir plus peginterferon alfa-2a and ribavirin in treatment-naïve patients with hepatitis C virus genotype 1 infectionPatrick Marcellin, Curtis Cooper, Luis Balart, et al.Nature Communications|April 28, 2019
Cryo-EM structures of the pore-forming A subunit from the Yersinia entomophaga ABC toxinSarah J Piper, Lou Brillault, Rosalba Rothnagel, et al.Pageof 117